Crescent Capital BDC Inc. (CCAP) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Crescent Capital BDC Inc.

    NASDAQ: CCAP · Real-Time Price · USD
    15.81
    -0.05 (-0.32%)
    At close: Sep 09, 2025, 3:59 PM
    15.81
    0.00%
    After-hours: Sep 09, 2025, 04:10 PM EDT

    Crescent Capital BDC Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 194.85M 172.69M 121.69M 126.29M
    Cost of Revenue
    		 58.93M 36.6M 20.47M 19.47M
    Gross Profit
    		 197.36M 136.09M 101.23M 106.82M
    Operating Income
    		 138.67M 144.29M 48.42M 106.73M
    Interest Income
    		 182.94M 169.87M 108.52M 85.66M
    Pretax Income
    		 74.74M 84.11M 16.5M 87.28M
    Net Income
    		 73.65M 83.84M 15.54M 83.63M
    Selling & General & Admin
    		 5.21M 4.95M 4.49M 4.87M
    Research & Development
    		 n/a n/a n/a n/a
    Other Expenses
    		 3.56M 3.4M 2.18M -7.22M
    Operating Expenses
    		 8.76M 8.35M 6.67M -2.35M
    Interest Expense
    		 58.93M 54.88M 28.93M 16.17M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 56.17M 28.4M 73.28M 19.55M
    Income Tax Expense
    		 1.09M 274K 961K 3.65M
    Shares Outstanding (Basic)
    		 37.06M 35.93M 30.89M 28.48M
    Shares Outstanding (Diluted)
    		 37.06M 35.93M 30.89M 28.48M
    EPS (Basic)
    		 1.99 2.33 0.50 2.94
    EPS (Diluted)
    		 1.99 2.33 0.50 2.94
    EBITDA
    		 138.67M 144.29M 48.42M 106.73M
    EBIT
    		 138.67M 144.29M 48.42M 106.73M
    Depreciation & Amortization
    		 n/a n/a n/a n/a

    Add to Watchlist